A clinical phase II study of vinorelbine and oxaliplatin (Vinox) with or without trastuzumab (Herceptin) in advanced breast carcinoma

Trial Profile

A clinical phase II study of vinorelbine and oxaliplatin (Vinox) with or without trastuzumab (Herceptin) in advanced breast carcinoma

Discontinued
Phase of Trial: Phase II

Latest Information Update: 03 Nov 2008

At a glance

  • Drugs Oxaliplatin; Trastuzumab; Vinorelbine
  • Indications Advanced breast cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 03 Nov 2008 Trial sponsor 'American University of Beirut Medical Center' added as reported by ClinicalTrials.gov.
    • 01 Aug 2008 Status changed from recruiting to discontinued, from clinicaltrials.gov record.
    • 02 Mar 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top